Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
Autor principal: | Wilcock, G |
---|---|
Formato: | Book section |
Publicado em: |
2004
|
Registos relacionados
-
Methodological issues in primary prevention trials for neurodegenerative dementia.
Por: Andrieu, S, et al.
Publicado em: (2009) -
Dementia with Lewy bodies.
Por: Wilcock, G
Publicado em: (2003) -
The ageing brain and dementia.
Por: Wilcock, G
Publicado em: (1981) -
Memantine for the treatment of dementia.
Por: Wilcock, G
Publicado em: (2003) -
A review of dementia.
Por: Wilcock, G
Publicado em: (1982)